Holen Sie sich die Stockscreener-App
1.65
0.60%
-0.01
Handel nachbörslich:
1.70
0.05
+3.03%
Schlusskurs vom Vortag:
$1.66
Offen:
$1.71
24-Stunden-Volumen:
198.48K
Relative Volume:
0.78
Marktkapitalisierung:
$3.08M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-25.56M
KGV:
-0.3173
EPS:
-5.2
Netto-Cashflow:
$-19.35M
1W Leistung:
-1.20%
1M Leistung:
-76.39%
6M Leistung:
-9.84%
1J Leistung:
-30.38%
1-Tages-Spanne:
$1.62
$1.72
1-Wochen-Bereich:
$1.60
$1.84
52-Wochen-Spanne:
$0.62
$9.56
Biovie Inc Stock (BIVI) Company Profile
Firmenname
Biovie Inc
Sektor
Branche
Telefon
775-888-3162
Adresse
680 W NYE LANE, CARSON CITY
Vergleichen Sie BIVI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIVI
Biovie Inc
|
1.65 | 3.08M | 0 | -25.56M | -19.35M | -5.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Biovie Inc Stock (BIVI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-07-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-01-15 | Eingeleitet | B. Riley Securities | Buy |
Biovie Inc Aktie (BIVI) Neueste Nachrichten
What hedge funds are buying BioVie Inc.Weekly Trade Recap & Real-Time Market Sentiment Reports - mustnews.co.kr
BioVie stock dips on pricing $12M securities offering - MSN
Can BioVie Inc. deliver alphaJuly 2025 Drop Watch & AI Driven Price Predictions - newsimpact.co.kr
Will BioVie Inc. announce a stock split2025 Volatility Report & Stepwise Trade Signal Guides - thegnnews.com
New to The Street to Air Show #683 on Bloomberg, Featuring BioVie, FLOKI, PetVivo, and NRx Pharmaceuticals - The Florida Times-Union
How high can BioVie Inc. stock price go in 2025Earnings Trend Report & Weekly High Conviction Ideas - Newser
Smart tools for monitoring BioVie Inc.’s price action2025 Fundamental Recap & Accurate Trade Setup Notifications - Newser
Understanding BioVie Inc.’s price movementTake Profit & Long-Term Capital Growth Strategies - Newser
BioVie Inc. Presents Phase 2 ADDRESS-LC Trial Design for Bezisterim in Long COVID at Keystone Symposia - Quiver Quantitative
BioVie Highlighted ADDRESS-LC Phase 2 Trial Design - GlobeNewswire
BioVie's Novel Long COVID Drug Trial Targets Brain Fog and Fatigue in 18M+ Americans - Stock Titan
BioVie Inc. stock prediction for this weekAI Trend Detection for Entry Timing - Newser
Sector ETF performance correlation with BioVie Inc.Entry and Exit Strategy for Swing Traders - Newser
BioVie Completes $10.4 Million Public Offering to Strengthen Financial Position - AInvest
Has BioVie Inc. found a price floorPortfolio Risk Distribution Analysis Tool - Newser
BioVie Completes $10.4 Million Public Offering - TipRanks
BioVie closes $12 million public offering of units - Investing.com
BioVie closes $12 million public offering of units By Investing.com - Investing.com UK
BioVie Inc. Announces Closing of $12 Million Public Offering - GlobeNewswire
BioVie Inc. Raises $12 Million Through Public Offering - AInvest
BioVie Secures $12M Financing: Units at $2.00 Include 5-Year Warrants for Drug Development Pipeline - Stock Titan
What machine learning models say about BioVie Inc.Real-Time Setup Summary with ROI Focus - Newser
Why BioVie Inc. stock is on top investor watchlistsReal-Time Investment Picks with Accuracy - Newser
What is the short-term price target for BIVI according to analyst ratings? - AInvest
Bloomberg to Air New to The Street Episode #683 Featuring BioVie, FLOKI, PetVivo, and NRx Pharmaceuticals - AInvest
BioVie Raises $12mln, Sees Upside to $55.00, Analysts Call it an "Outperform" Investment Opportunity - AInvest
BioVie Prices 6M Share Secondary at $2.00, Below Last Closing Price of $2.91 - AInvest
BioVie Inc. Announces Pricing of $12 Million Public Offering - GlobeNewswire
BioVie (BIVI.O) Crashes 42.78%: What's Behind the Sharp Intraday Move? - AInvest
Biovie stock plunges after pricing $12 million public offering By Investing.com - Investing.com Canada
Biovie stock plunges after pricing $12 million public offering - Investing.com
S&P 500 Moves Higher; Under Armour Shares Tumble After Q1 Results - Benzinga
BioVie's 45% Plunge: A Capital Raise Gone Wrong? - AInvest
US Stocks Surge as Dow Gains 300 Points, American Axle & Mfg Posts Upbeat Earnings - AInvest
Dow Surges 300 Points; American Axle & Manufacturing Posts Upbeat Earnings - Benzinga
BioVie Announces $12M Securities Offering - AInvest
BioVie's (BIVI) 43% Plunge: A Volatile Turn in the Biotech Arena? - AInvest
BioVie Stock Dips After Share Offering News - timothysykes.com
Why Is BioVie Stock (BIVI) Down 50% Today? - TipRanks
Why Expedia Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga
Clinical-Stage Biotech BioVie Secures $12M Financing: Key Details of Stock and Warrant Offering Revealed - Stock Titan
BioVie prices $12 million public offering of units at $2.00 each - Investing.com
Biovie's $12M Equity Raise: Is This a Strategic Lifeline or a Warning Signal for Small-Cap Biotechs? - AInvest
BioVie Inc. Raises $12 Million in Public Offering - AInvest
Biovie announces pricing of $12 million public offering - MarketScreener
Biovie Announces Pricing Of $12 Million Public Offering - TradingView
BioVie Inc. Announces Pricing of $12 Million Public Offering - Benzinga
Real time scanner hits for BioVie Inc. explainedTrading Volume Anomaly Summary and Insight - Newser
What is the risk reward ratio of investing in BioVie Inc. stockHigh-velocity gains - Jammu Links News
Is it the right time to buy BioVie Inc. stockSkyrocketing profit margins - Jammu Links News
What catalysts could drive BioVie Inc. stock higher in 2025Achieve rapid returns with smart investment plans - Jammu Links News
Finanzdaten der Biovie Inc-Aktie (BIVI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):